乐心医疗收盘上涨1.60%，滚动市盈率50.67倍，总市值35.79亿元

Group 1 - The core business of the company is health IoT and digital health services, with main products including smart electronic blood pressure monitors, electronic health scales, smart blood glucose monitoring products, body fat measurement devices, ECG monitoring equipment, smart bands, and smart watches [2] - The company is recognized as a national high-tech enterprise and has established several engineering technology research centers, focusing on the R&D, production, and sales of home medical health electronic products [2] - The company has achieved various international certifications, including ISO13485:2016 for medical device quality management, and its products have received FDA registration in the US, CE certification in the EU, and other international certifications [2] Group 2 - As of August 1, the company's stock closed at 16.46 yuan, with a rolling PE ratio of 50.67 times and a total market value of 3.579 billion yuan [1] - The average PE ratio in the medical device industry is 53.65 times, with a median of 37.22 times, placing the company at the 87th position in the industry ranking [1][3] - The latest quarterly report for Q1 2025 shows the company achieved a revenue of 273 million yuan, a year-on-year increase of 9.90%, and a net profit of 22.942 million yuan, a year-on-year increase of 67.88%, with a gross profit margin of 37.38% [2]